시장보고서
상품코드
1331605

세계의 전임상 CRO 시장(2023-2027년)

Global Preclinical CRO Market 2023-2027

발행일: | 리서치사: TechNavio | 페이지 정보: 영문 152 Pages | 배송안내 : 즉시배송


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

전임상 CRO 시장은 2022-20271년에 22억 5,355만 달러, 예측 기간 중 CAGR은 7.71%로 성장할 것으로 예측되고 있습니다.

전임상 CRO 시장의 전체적인 분석, 시장 규모·예측, 동향, 시장 촉진요인·촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 제공합니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 만성질환의 증가, 헬스케어 인프라에서 테크놀러지와 진보의 증가, 전임상 CRO에 관련된 비핵심 기능 아웃소싱의 증가 등이 시장을 촉진하고 있습니다.

임상시험 수의 증가를 향후 수년간 전임상 CRO 시장 성장을 촉진하는 주요인의 하나로 들고 있습니다. 또한 의약품 개발을 위한 R&D 예산의 증가, 신약 및 의료 치료에 대한 수요의 증가는 시장의 큰 수요로 연결됩니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 시장 구도

  • 시장 에코시스템

제3장 시장 규모

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모 2022
  • 시장 전망 2022-2027

제4장 시장 규모 실적

  • 세계의 전임상 CRO 시장 2017-2021
  • 최종사용자 부문 분석 2017-2021
  • 서비스 부문 분석 2017-2021
  • 지역별 부문 분석 2017-2021
  • 국가별 부문 분석 2017-2021

제5장 Five forces 분석

  • Five Forces 요약
  • 구매자의 교섭력
  • 공급 기업의 교섭력
  • 신규 진출업체의 위협
  • 대체품의 위협
  • 경쟁의 위협
  • 시장 현황

제6장 시장 세분화 : 최종사용자별

  • 시장 부문
  • 비교 : 최종사용자별
  • 제약회사 및 바이오의약품 회사 : 시장 규모와 예측 2022-2027
  • 의료기기 회사 : 시장 규모와 예측 2022-2027
  • 학술기관 : 시장 규모와 예측 2022-2027
  • 시장 기회 : 최종사용자별

제7장 시장 세분화 : 서비스별

  • 시장 부문
  • 비교 : 서비스별
  • 독물학 검사 : 시장 규모와 예측 2022-2027
  • 생물 분석과 DMPK 연구 : 시장 규모와 예측 2022-2027
  • 화합물 관리 : 시장 규모와 예측 2022-2027
  • 기타 : 시장 규모와 예측 2022-2027
  • 시장 기회 : 서비스별

제8장 고객 상황

  • 고객 상황의 개요

제9장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측 2022-2027
  • 유럽 : 시장 규모와 예측 2022-2027
  • 아시아 : 시장 규모와 예측 2022-2027
  • 세계의 기타 지역 : 시장 규모와 예측 2022-2027
  • 미국 : 시장 규모와 예측 2022-2027
  • 독일 : 시장 규모와 예측 2022-2027
  • 영국 : 시장 규모와 예측 2022-2027
  • 캐나다 : 시장 규모와 예측 2022-2027
  • 중국 : 시장 규모와 예측 2022-2027
  • 시장 기회 : 지역 상황별

제10장 촉진요인, 과제 및 동향

  • 시장 촉진요인
  • 시장이 해결해야 할 과제
  • 촉진요인과 과제의 영향
  • 시장 동향

제11장 벤더 구도

  • 개요
  • 벤더 구도
  • 혼란의 상황
  • 업계의 리스크

제12장 벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • Altasciences
  • AmplifyBio
  • Charles River Laboratories International Inc.
  • Eurofins Scientific SE
  • ICON plc
  • Imavita S.A.S.
  • IQVIA Inc.
  • JSR Corp.
  • Kunming Biomed International Ltd.
  • Laboratory Corp. of America Holdings
  • Medpace Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • Veeda Clinical Research Ltd.
  • Vivotecnia
  • WuXi AppTec Co. Ltd.

제13장 부록

KSA 23.08.30

The preclinical CRO market is forecasted to grow by USD 2253.55 mn during 2022-2027, accelerating at a CAGR of 7.71% during the forecast period. The report on the preclinical CRO market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increase in technology and advancements in healthcare infrastructure, and growth in outsourcing of non-core functions related to preclinical CRO.

Technavio's preclinical CRO market is segmented as below:

By End-user

  • Pharmaceutical and biopharmaceutical companies
  • Medical device companies
  • Academic institutes

By Service

  • Toxicology testing
  • Bioanalysis and DMPK studies
  • Compound management
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increasing number of clinical trials as one of the prime reasons driving the preclinical CRO market growth during the next few years. Also, rise in R and D budget for drug development and increasing demand for new drugs and medical treatments will lead to sizable demand in the market.

The report on the preclinical CRO market covers the following areas:

  • Preclinical CRO market sizing
  • Preclinical CRO market forecast
  • Preclinical CRO market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading preclinical CRO market vendors that include Altasciences, AmplifyBio, BioEmission Technology Solutions, Charles River Laboratories International Inc., CYNBIOSE, Eurofins Scientific SE, Gempharmatech Co. Ltd., Global Center for Medical Innovation, ICON plc, Imavita S.A.S., IQVIA Inc., JSR Corp., Kunming Biomed International Ltd., Laboratory Corp. of America Holdings, Medpace Holdings Inc., Parexel International Corp., Thermo Fisher Scientific Inc., Veeda Clinical Research Ltd., WuXi AppTec Co. Ltd., and Vivotecnia. Also, the preclinical CRO market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Service
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global preclinical CRO market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global preclinical cro market 2017 - 2021 ($ million)
  • 4.2 End-user Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • 4.3 Service Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Service Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

  • 6.1 Market segments
  • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
  • 6.2 Comparison by End-user
  • Exhibit 32: Chart on Comparison by End-user
  • Exhibit 33: Data Table on Comparison by End-user
  • 6.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)
  • 6.4 Medical device companies - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Medical device companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Medical device companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Medical device companies - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Medical device companies - Year-over-year growth 2022-2027 (%)
  • 6.5 Academic institutes - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Academic institutes - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Data Table on Academic institutes - Market size and forecast 2022-2027 ($ million)
  • Exhibit 44: Chart on Academic institutes - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Academic institutes - Year-over-year growth 2022-2027 (%)
  • 6.6 Market opportunity by End-user
  • Exhibit 46: Market opportunity by End-user ($ million)
  • Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Service

  • 7.1 Market segments
  • Exhibit 48: Chart on Service - Market share 2022-2027 (%)
  • Exhibit 49: Data Table on Service - Market share 2022-2027 (%)
  • 7.2 Comparison by Service
  • Exhibit 50: Chart on Comparison by Service
  • Exhibit 51: Data Table on Comparison by Service
  • 7.3 Toxicology testing - Market size and forecast 2022-2027
  • Exhibit 52: Chart on Toxicology testing - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Data Table on Toxicology testing - Market size and forecast 2022-2027 ($ million)
  • Exhibit 54: Chart on Toxicology testing - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on Toxicology testing - Year-over-year growth 2022-2027 (%)
  • 7.4 Bioanalysis and DMPK studies - Market size and forecast 2022-2027
  • Exhibit 56: Chart on Bioanalysis and DMPK studies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Data Table on Bioanalysis and DMPK studies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 58: Chart on Bioanalysis and DMPK studies - Year-over-year growth 2022-2027 (%)
  • Exhibit 59: Data Table on Bioanalysis and DMPK studies - Year-over-year growth 2022-2027 (%)
  • 7.5 Compound management - Market size and forecast 2022-2027
  • Exhibit 60: Chart on Compound management - Market size and forecast 2022-2027 ($ million)
  • Exhibit 61: Data Table on Compound management - Market size and forecast 2022-2027 ($ million)
  • Exhibit 62: Chart on Compound management - Year-over-year growth 2022-2027 (%)
  • Exhibit 63: Data Table on Compound management - Year-over-year growth 2022-2027 (%)
  • 7.6 Others - Market size and forecast 2022-2027
  • Exhibit 64: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 65: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 66: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibit 67: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • 7.7 Market opportunity by Service
  • Exhibit 68: Market opportunity by Service ($ million)
  • Exhibit 69: Data Table on Market opportunity by Service ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 73: Chart on Geographic comparison
  • Exhibit 74: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 UK - Market size and forecast 2022-2027
  • Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.10 Canada - Market size and forecast 2022-2027
  • Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.11 China - Market size and forecast 2022-2027
  • Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 111: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 113: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 115: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 116: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 117: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 118: Matrix on vendor position and classification
  • 12.3 Altasciences
  • Exhibit 119: Altasciences - Overview
  • Exhibit 120: Altasciences - Product / Service
  • Exhibit 121: Altasciences - Key offerings
  • 12.4 AmplifyBio
  • Exhibit 122: AmplifyBio - Overview
  • Exhibit 123: AmplifyBio - Product / Service
  • Exhibit 124: AmplifyBio - Key offerings
  • 12.5 Charles River Laboratories International Inc.
  • Exhibit 125: Charles River Laboratories International Inc. - Overview
  • Exhibit 126: Charles River Laboratories International Inc. - Business segments
  • Exhibit 127: Charles River Laboratories International Inc. - Key news
  • Exhibit 128: Charles River Laboratories International Inc. - Key offerings
  • Exhibit 129: Charles River Laboratories International Inc. - Segment focus
  • 12.6 Eurofins Scientific SE
  • Exhibit 130: Eurofins Scientific SE - Overview
  • Exhibit 131: Eurofins Scientific SE - Business segments
  • Exhibit 132: Eurofins Scientific SE - Key news
  • Exhibit 133: Eurofins Scientific SE - Key offerings
  • Exhibit 134: Eurofins Scientific SE - Segment focus
  • 12.7 ICON plc
  • Exhibit 135: ICON plc - Overview
  • Exhibit 136: ICON plc - Product / Service
  • Exhibit 137: ICON plc - Key offerings
  • 12.8 Imavita S.A.S.
  • Exhibit 138: Imavita S.A.S. - Overview
  • Exhibit 139: Imavita S.A.S. - Product / Service
  • Exhibit 140: Imavita S.A.S. - Key offerings
  • 12.9 IQVIA Inc.
  • Exhibit 141: IQVIA Inc. - Overview
  • Exhibit 142: IQVIA Inc. - Business segments
  • Exhibit 143: IQVIA Inc. - Key news
  • Exhibit 144: IQVIA Inc. - Key offerings
  • Exhibit 145: IQVIA Inc. - Segment focus
  • 12.10 JSR Corp.
  • Exhibit 146: JSR Corp. - Overview
  • Exhibit 147: JSR Corp. - Business segments
  • Exhibit 148: JSR Corp. - Key offerings
  • Exhibit 149: JSR Corp. - Segment focus
  • 12.11 Kunming Biomed International Ltd.
  • Exhibit 150: Kunming Biomed International Ltd. - Overview
  • Exhibit 151: Kunming Biomed International Ltd. - Product / Service
  • Exhibit 152: Kunming Biomed International Ltd. - Key offerings
  • 12.12 Laboratory Corp. of America Holdings
  • Exhibit 153: Laboratory Corp. of America Holdings - Overview
  • Exhibit 154: Laboratory Corp. of America Holdings - Business segments
  • Exhibit 155: Laboratory Corp. of America Holdings - Key news
  • Exhibit 156: Laboratory Corp. of America Holdings - Key offerings
  • Exhibit 157: Laboratory Corp. of America Holdings - Segment focus
  • 12.13 Medpace Holdings Inc.
  • Exhibit 158: Medpace Holdings Inc. - Overview
  • Exhibit 159: Medpace Holdings Inc. - Product / Service
  • Exhibit 160: Medpace Holdings Inc. - Key offerings
  • 12.14 Thermo Fisher Scientific Inc.
  • Exhibit 161: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 162: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 163: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 164: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 165: Thermo Fisher Scientific Inc. - Segment focus
  • 12.15 Veeda Clinical Research Ltd.
  • Exhibit 166: Veeda Clinical Research Ltd. - Overview
  • Exhibit 167: Veeda Clinical Research Ltd. - Product / Service
  • Exhibit 168: Veeda Clinical Research Ltd. - Key offerings
  • 12.16 Vivotecnia
  • Exhibit 169: Vivotecnia - Overview
  • Exhibit 170: Vivotecnia - Product / Service
  • Exhibit 171: Vivotecnia - Key offerings
  • 12.17 WuXi AppTec Co. Ltd.
  • Exhibit 172: WuXi AppTec Co. Ltd. - Overview
  • Exhibit 173: WuXi AppTec Co. Ltd. - Business segments
  • Exhibit 174: WuXi AppTec Co. Ltd. - Key offerings
  • Exhibit 175: WuXi AppTec Co. Ltd. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 176: Inclusions checklist
  • Exhibit 177: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 178: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 179: Research methodology
  • Exhibit 180: Validation techniques employed for market sizing
  • Exhibit 181: Information sources
  • 13.5 List of abbreviations
  • Exhibit 182: List of abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제